Site Content

 At our primary care clinic, we are pleased to offer FibroScan®, an advanced, evidence-based diagnostic tool for the non-invasive evaluation of liver health. FibroScan® (Transient Elastography) is an FDA-approved technology that measures liver stiffness and controlled attenuation parameter (CAP) values to assess the degree of fibrosis and steatosis. These parameters provide critical insights into liver conditions such as nonalcoholic fatty liver disease (NAFLD), nonalcoholic steatohepatitis (NASH), alcohol-related liver disease, chronic hepatitis B and C, and other causes of chronic liver injury.

Unlike traditional liver biopsy, FibroScan® is painless, rapid, and non-invasive, requiring no sedation or recovery time. The procedure typically takes less than 10 minutes and delivers immediate, quantitative results. This allows our provider to accurately monitor liver health, detect early signs of disease progression, and guide individualized treatment and lifestyle recommendations.

Clinical studies have demonstrated that FibroScan® offers reliable and reproducible assessments of liver fibrosis, with strong correlation to histologic findings. Incorporating this technology into our primary care setting enhances our ability to deliver proactive, preventive, and data-driven care, ensuring timely intervention and improved patient outcomes.